Selective depletion of regulatory t cell subsets by docetaxel treatment in patients with nonsmall cell lung cancer

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Li, Jie Yao ^a   Duan, Xiu Fang ^a   Wang, Li Ping ^a   Xu, Yu Jie ^a   Huang, Lan ^a   Zhang, Teng Fei ^a   Liu, Jin Yan ^a,b   Li, Feng ^a   Zhang, Zhen ^a   Yue, Dong Li ^a   Wang, Fei ^a,b   Zhang, Bin ^c   Zhang, Yi ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD39 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CISPLATIN; DOCETAXEL; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER STAGING; CELL DEATH; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MULTIPLE CYCLE TREATMENT; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CASE CONTROL STUDY; CELL LINEAGE; CLASSIFICATION; DRUG EFFECTS; IMMUNOLOGY; IMMUNOPHENOTYPING; LUNG NEOPLASMS; LYMPHOCYTE DEPLETION; MIDDLE AGED; PATHOLOGY;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CELL LINEAGE; FEMALE; HUMANS; IMMUNOPHENOTYPING; LUNG NEOPLASMS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; NEOPLASM STAGING; T-LYMPHOCYTES, REGULATORY; TAXOIDS;

EID: 84901044443     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/286170     Document Type: Article

References (39)

1. Zou W., Regulatory T cells, tumour immunity and immunotherapy. Nature Reviews Immunology 2006 6 4 295 307 2-s2.0-33645286546 10.1038/nri1806
2. Curiel T. J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J. R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M. L., Knutson K. L., Chen L., Zou W., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine 2004 10 9 942 949 2-s2.0-4644237613 10.1038/nm1093 (Pubitemid 39273735)
3. Stoop J. N., van der Molen R. G., Baan C. C., van der Laan L. J. W., Kuipers E. J., Kusters J. G., Janssen H. L. A., Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005 41 4 771 778 2-s2.0-16244385911 10.1002/hep.20649 (Pubitemid 40462939)
4. + regulatory T cells in autoimmune polyglandular syndrome type II. The Journal of Experimental Medicine 2004 199 9 1285 1291 2-s2.0-2442628376 10.1084/jem.20032158 (Pubitemid 38620265)
5. Deaglio S., Dwyer K. M., Gao W., Friedman D., Usheva A., Erat A., Chen J.-F., Enjyoji K., Linden J., Oukka M., Kuchroo V. K., Strom T. B., Robson S. C., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. The Journal of Experimental Medicine 2007 204 6 1257 1265 2-s2.0-34250351459 10.1084/jem.20062512 (Pubitemid 46919862)
6. Mandapathil M., Szczepanski M. J., Szajnik M., Ren J., Lenzner D. E., Jackson E. K., Gorelik E., Lang S., Johnson J. T., Whiteside T. L., Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer. Clinical Cancer Research 2009 15 20 6348 6357 2-s2.0-70350231926 10.1158/1078-0432.CCR-09-1143
7. Nadkarni S., Mauri C., Ehrenstein M. R., Anti-TNF- α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF- β The Journal of Experimental Medicine 2007 204 1 33 39 2-s2.0-33846446041 10.1084/jem.20061531 (Pubitemid 46148753)
8. Rao P. E., Petrone A. L., Ponath P. D., Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF- β The Journal of Immunology 2005 174 3 1446 1455 2-s2.0-12444279957
9. + regulatory T cells in human thymus and periphery. Immunity 2008 28 6 870 880 2-s2.0-44649189089 10.1016/j.immuni.2008.03.018
10. + regulatory T cells. Nature Immunology 2003 4 4 330 336 2-s2.0-0037385330 10.1038/ni904 (Pubitemid 36432314)
11. - T cells by T-cell receptor stimulation is transforming growth factor- β-dependent but does not confer a regulatory phenotype. Blood 2007 110 8 2983 2990 2-s2.0-35448930435 10.1182/blood-2007-06-094656 (Pubitemid 350006952)
12. + regulatory T cells in immunological tolerance to self and non-self. Nature Immunology 2005 6 4 345 352 2-s2.0-16844365788 10.1038/ni1178 (Pubitemid 41716771)
13. + T cells expressing the FoxP3 transcription factor. Immunity 2009 30 6 899 911 2-s2.0-66949171924 10.1016/j.immuni.2009.03.019
14. Lin Y.-C., Mahalingam J., Chiang J.-M., Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer. International Journal of Cancer 2013 132 6 1341 1350 10.1002/ijc.27784
15. Mathian A., Parizot C., Dorgham K., Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions. Annals of the Rheumatic Diseases 2012 71 7 1227 1234 10.1136/annrheumdis-2011-200709
16. Curiel T. J., Tregs and rethinking cancer immunotherapy. The Journal of Clinical Investigation 2007 117 5 1167 1174 2-s2.0-34248194231 10.1172/JCI31202 (Pubitemid 46718401)
17. - responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia. Immunology 2014 142 1 124 139 10.1111/imm.12237
18. + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Research 2001 61 12 4766 4772 2-s2.0-0035874949 (Pubitemid 32691889)
19. Marshall N. A., Christie L. E., Munro L. R., Culligan D. J., Johnston P. W., Barker R. N., Vickers M. A., Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 2004 103 5 1755 1762 2-s2.0-1442283424 10.1182/blood-2003-07-2594 (Pubitemid 38268969)
20. Ichihara F., Kono K., Takahashi A., Kawaida H., Sugai H., Fujii H., Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clinical Cancer Research 2003 9 12 4404 4408 2-s2.0-0141891466 (Pubitemid 37248397)
21. Chan O. T. M., Yang L.-X., The immunological effects of taxanes. Cancer Immunology, Immunotherapy 2000 49 4-5 181 185 10.1007/s002620000122 (Pubitemid 30484824)
22. + FOXP 3neg T-cell subsets in cancer patients. European Journal of Immunology 2012 42 7 1876 1885 10.1002/eji.201142347
23. + regulatory T Cells. The Journal of Biological Chemistry 2010 285 10 7176 7186 2-s2.0-77951234655 10.1074/jbc.M109.047423
24. Turk M. J., Guevara-Patiño J. A., Rizzuto G. A., Engelhorn M. E., Houghton A. N., Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. The Journal of Experimental Medicine 2004 200 6 771 782 2-s2.0-4644342928 10.1084/jem.20041130 (Pubitemid 39299463)
25. Beyer M., Schultze J. L., Regulatory T cells in cancer. Blood 2006 108 3 804 811 2-s2.0-33746599842 10.1182/blood-2006-02-002774 (Pubitemid 44154611)
26. Ganesan A.-P., Johansson M., Ruffell B., Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma. The Journal of Immunology 2013 191 4 2009 2017 10.4049/jimmunol.1301317
27. + cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. The Journal of Experimental Medicine 2005 201 5 779 791 2-s2.0-15444377017 10.1084/jem.20041684 (Pubitemid 40395122)
28. + Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007 110 4 1225 1232 2-s2.0-34547098277 10.1182/blood-2006-12-064527 (Pubitemid 47281420)
29. - T cells. The FASEB Journal 2008 22, supplement 848.16
30. Letterio J. J., Roberts A. B., Regulation of immune responses by TGF- β Annual Review of Immunology 1998 16 137 161 2-s2.0-0031944290 10.1146/annurev.immunol.16.1.137 (Pubitemid 28183362)
31. Li M. O., Sanjabi S., Flavell R., Transforming growth factor- β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006 25 3 455 471 2-s2.0-33748448717 10.1016/j.immuni.2006.07.011 (Pubitemid 44354214)
32. + T cell homeostasis but dispensable for regulatory T cell function. PLOS Biology 2013 11 10 e1001674 10.1371/journal.pbio.1001674
33. Sojka D. K., Fowell D. J., Regulatory T cells inhibit acute IFN- γ synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10. Proceedings of the National Academy of Sciences of the United States of America 2011 108 45 18336 18341 2-s2.0-81055126124 10.1073/pnas.1110566108
34. G E., Haribhai D., Williams J. B., IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy. The Journal of Immunology 2012 189 12 5638 5648 10.4049/jimmunol.1200936
35. + T regulatory lymphocytes. Cancer Immunology, Immunotherapy 2013 62 5 851 862 10.1007/s00262-013-1392-z
36. + regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 2010 139 3 1030 1040 2-s2.0-77956134431 10.1053/j.gastro.2010.05.007
37. + T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia. Annals of Hematology 2012 91 8 1271 1279 2-s2.0-84856778954 10.1007/s00277-012-1425-2
38. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA: A Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
39. McCoy M. J., Lake R. A., van der Most R. G., Dick I. M., Nowak A. K., Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies. British Journal of Cancer 2012 107 7 1107 1115 10.1038/bjc.2012.362